produce an 'A L E' lesion. 15 of 44 serotypablc EPEC s t r a i n s and 6 o f 297 E. c o l i i s o l a t e s were p o s i t i v e i n the FAS t e s t . A11 6 FA5 Test-positive E.coli were subsequently shown t o adhere also t o c u l t u r e d human small i n t e s t i n a l mucosa and t o produce an 'A 6 E' leion. Only 1 o f the 6 was subsequently found t o belong t o a c l a s s i c a l EPEC seragroup (0127). These r e s u l t s show: 1. The FAS t e s t i d e n t i f i e s 'A 6 E' E. c o l i which would not have been detected by serotyping. These 'A 6 E' E.coli which belong t o non-classical EPEC serogroups a r e most probably human E.coli pathogens which have previously gone unrecognised. 2. There i s no c o r r e l a t i o n between EPEC seratyping and t h e a b i l i t y t o cause the 'A 6. E' lesion. 3. The FAS Test i s a useful a d d i t i o n t o the current range o f diagnostic t e s t s f o r human E. c o l i e n t e r i c pathogens. It is mluded that t k mination of rnterral protein mlmtrition ard e t b m l e x m r e in utero alters tk rt?gAaticn of pnressirg i n developing k p t c c y k which my retard kptocellular mturaticm and developwnt.
It is mluded that t k mination of rnterral protein mlmtrition ard e t b m l e x m r e in utero alters tk rt?gAaticn of pnressirg i n developing k p t c c y k which my retard kptocellular mturaticm and developwnt.
-. P r e v i a s studies a t DNA aml prcduct level of B c e l l l i n e s onCD p a t i e n t s have shcwn a strcng a s s o c h t i c n tetweenCD nd t h e HLA-W2.3 ard HIS.-IQ 82.7 alleles1. The r a t m n w l m a l SEX-20& h i c h specif i c a l l y reccgnizes theHLA--2.3 specificity2 aml t h e m c n c c l m l directed against them-CQa2.7 s p e c i f i c i t y ( P C Mazzili,Italy) have been used t o d e t e c t theexpression of these s p e c i f i c i t i e s a t theSIM in 7 CDpatients aml6ncn<Dpatient~.ThemcusemonoclmalSW-L3 against HLA-DQbacktone was used as p o s i t i v e h n m q e r w i d a s e control. An irmuncperoxidase technique m f r o z e n t i s s u e sections of jejunal bicpsy specimenwas used. Results: Pas i t i v e s p e c h s s h a w l an i n f i l t r a t i o n of p c s i t ive lynfocytes a r d h i s t i m y t s i n t h e laminapropria. P a s i t i v e r e s u l t s a t t h e i n t e s t i n a l 1t.elcorrelated withHLA typing of t h e p a t i e n t s ardccntrols.
The e p i t h e l i a l c e l l s werenegative.
Peripheral blocd Small intestine DR3 DR7 DR3/7 DR-/-W2 W 2 . 3 DQP2.7 IQ Cmclus ion: The r e s u l t s shcw t h a t a t i n t e s t i n a l level t h e W-tQ spec if ic a l l e l e s associated withCD a r e n o t expressed in t h e e p i t h e l i a l c e l l s but a h n d a n t l y present i n lamina prcpr ia c e l l s of c e l i a c patients. This d i s t r ibt ion m y st h e hypothes is t h a t t h e s e W r n o l m l e s a r e inw l m in t h e regulation of t h e i n t e s t i n a l imune respcmse t o gluten.
METABOLISM OF FETAL BILE ACIDS IN HEALTHY 'NEONATES
and Hasahiko Tohma2, Department o f Pediatrics, Juntendo University, Tokyo, Higashi-Nippon-Cakuen U n i v e r s i t y o f Hokkaido, Japan2. I n order t o c l a r i f y the b i l e a c i d metabolism during the neonatal period, we measured f e t a l b i l e acids i n the u r i n e o f f u l l term neonates using s p e c i f i c q u a n t i t a t i v e assay by c a p i l l a r y CC w i t h negative i o n chemical i o n i z a t i o n MS. Spot u r i n e samples o f 15 f u l l term neonates were taken 1-5 days a f t e r b i r t h . As controls, spot u r i n e samples of 10 h e a l t h c h i l d r e n aged 4-8 years were analysed. B i l e acids were extracted from u r i n e using Bond-Elut C cartridge.
A f t e r s o l v o l y s i r and a l k a l i n e hydrolysis, the f r e e b i l e acids we!: d e r i v a t i r e d t a t h e pentafluorobenzyl ester and t r i m e t h y l s i l y l ether.
I n the neonates, the percentage o f t o t a l 19-hydroxylated b i l e acids was s i g n i f i c a n t l y higher than t h a t i n the older children. The percentages of 36, I&-5-cholenic a c i d and hyochalic a c i d i n the neonates were h i g h compared t o those i n the older children. The r a t i o s o f I g -CA/CA and 18 -CDCA/CDCA i n the neonates were s i g n i f i c a n t l y higher than those i n the older children.
The r a t i o s of CA/CDCA and 3 , 12u -5-cholenoic a c i d / ?g -5-chalenoic a c i d
were also s i g n i f i c a n t l y higher i n the neonates than those i n the older children. I t suggests t h a t l g and 121, hydroxylation o f b i l e acids a r e important metab o l i c pathways of b i l e acids i n neonates.
IMPROVEMENT OF CHOLESCINTICRAPHY IN THE DIFFERENTIAL DIAGNOSIS OF EXTRAHEPATIC
BILIARY ATRESIA 39 J .Deutsch*. R. Nicoletti, C. F. Fueqer Department of Paediatrics*, and Unit of Nuclear Medicine at t h e Institute of Radiology, University of Craz, Austria The introduction of halogenated analogs of iminodiacetic acid (IDA) has increased t h e effectivity of cholescintigraphy in t h e differential diagnosis of extrahepatic biliary atresia (EHBAI . We attempted t o evaluate cholescintigraphy with regard to its potential in increasing the effectivity and predictive value in t h e diagnosis of EHBA.
We studied 16 patients ( 3 with EHBA, weight = 2.45-6 kg,direct bilirubin 1.6-17.9 mgldll by 18 tests. 99mTc mebrofenin ( n = 5 ) and 99mTc lodida (n=131 were used a s tracers in intermittant sequential scintigraphy to 24 hrs. The data were evaluated by a computer program to obtain 13 kinetic parameters, and were compared with t h e results of t h e conventional scintigraphic interpretation.
The positive predictive value of the test increased to 80 % by measurement of t h e maximum intestinal activity, and to 100 % by evaluation of t h e hepatic tracer clearance. Combining t h e maximum intestinal activity with the hepatic tracer retention o r clearance led to an effectivity and positive predictive value of 100 P,. The examination of liver indices ( 5 adjustment for background activity l had no value.
Conclusions: An automated evaluation of data characterizing the excretion of halogenated IDA derivatives into t h e intestine has the potential of allowing the differentiation of EHBA from intrahepatic diseases with high probability.We plan to perform prospective studies on larger numbers of infants.
During the two year period 1986/87, 271 babies were born t o h e p a t i t i s 8 surface atigen c a r r i e r mothers i n the English West Midlands. Babies were allocated sequentially i n t o e i t h e r treatment Croup A I 4 doses o f HBVax, Merck Sharp 6 Dohme, 10 mcg. i.m, a t b i r t h , 1, 2 and 6 months) or treatment Croup B (250 1.0. h e p a t i t i s B immunoglobulin IHBIC) a t b i r t h , combined w i t h t h e same vaccine schedule as Croup A). 172 babies were e n r o l l e d and data was a v a i l a b l e f a r analysis an 150 (870). protect a t r i s k i n f a n t s from p e r i o a t a l transmission of HBV. I n babies born t o the less i n f e c t i o u s c a r r i e r mothers i n our study (i.e. those not HBe Ag+) the a d d i t i o n of HBlC t o the schedule conferred no added b e n e f i t . I n i n f a n t s born t o HBe Ag+ mothers p r o t e c t i o n was enhanced by a d d i t i o n o f HBlC although transmission was s t i l l not prevented i n every care. I n utero i n f e c t i o n and slaw response t o vaccine may be implicated f a i l u r e mechanisms.
